| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-89755-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1276-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1276-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35207-10ug | |||
| Carrier-Free | NBP2-35207-1mg | |||
| Carrier-Free | NBP2-35207-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34900-10ug | |||
| Carrier-Free | NBP2-34900-1mg | |||
| Carrier-Free | NBP2-34900-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35068-1mg | |||
| Carrier-Free | NBP2-35068-100ug | |||
| Carrier-Free | NBP2-35068-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-59490-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-98937-50ul | |||
![Immunocytochemistry/Immunofluorescence: GMF-beta Antibody [NBP1-89755] - Staining of human cell line U-251 MG shows localization to nucleoplasm, nuclear bodies & cytosol. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/GMF-beta-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-89755-img0015.jpg "Immunocytochemistry/Immunofluorescence: GMF-beta Antibody [NBP1-89755] - Staining of human cell line U-251 MG shows localization to nucleoplasm, nuclear bodies & cytosol. Antibody staining is shown in green.")
![Immunohistochemistry: GMF-beta Antibody [NBP1-89755] - GMF-beta knockdown suppresses tumor growth & the formation of human-CD31 positive microvessels (hCD31-MVs) in orthotopic U87 xenograft modelsA. The cross-sectional appearance of xenografted gliomas from U87-mock group B. The cross-sectional appearance of xenografted gliomas from U87-shGMF-beta group. Gross tumor boundaries were delineated by white dotlines. C. A hCD31-microvessel & several hCD31-negative vessels in U87-mock tumor. D. No hCD31-MVs, only hCD31-negative vessels in U87-shGMF-beta tumor. Red solid arrows indicate hGMF-beta staining in tumor cells, black solid arrows show hCD31 staining on microvasular endothelia, & open arrows denote vessels negative for hCD31. Scale bar: 100 μm in upper pannels; 50 μm in lower pannels. E. Quantitative comparisons of gross tumor volume between U87-mock & U87-shGMF-beta group. F. Quantitative comparisons of hCD31-microvessel densities (MVDs) between U87-mock & U87-shGMF-beta group. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26515590), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-89755_rabbit-polyclonal-gmf-beta-antibody-310202416121977.jpg)
![Western Blot: GMF-beta Antibody [NBP1-89755] - Tubulogenesis of human U87 glioblastoma cells is inhibited by GMF-beta knockdownA. Protein levels of GMF-beta in human glial cell line (HEB) & human glioma cell lines of the different grades (CHG5, SHG44, U87). B. Assessment of GMF-beta knockdown in U87 cells by western blotting. C. Tube formation by U87 mock cells (left panel); impaired tube formation by U87-shGMF-beta cells (right panel). Inspection under a phase contrast fluorescent microscope (× 100). D. Quantified tubulogenesis of U87 mock cells & U87-shGMF-beta cells by pattern recognition system (left panel) & branch point counting system (right panel).*** indicates significant difference with P < 0.001. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26515590), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-89755_rabbit-polyclonal-gmf-beta-antibody-310202415371963.jpg)
![Western Blot: GMF-beta Antibody [NBP2-43647] - Various tissue extracts (50 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with GMF-beta antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/GMF-beta-Antibody-Western-Blot-NBP2-43647-img0003.jpg "Western Blot: GMF-beta Antibody [NBP2-43647] - Various tissue extracts (50 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with GMF-beta antibody diluted at 1:1000.")
![Immunohistochemistry-Paraffin: GMF-beta Antibody [NBP2-43647] - Analysis of BT474 xenograft, using GMF beta antibody at 1:500 dilution.](http://images.novusbio.com/fullsize/GMF-beta-Antibody-Immunohistochemistry-Paraffin-NBP2-43647-img0001.jpg)
![Western Blot: GMF-beta Antibody [NBP2-43647] - Analysis of 30 ug whole cell lysate. A: Raji 15% SDS PAGE diluted at 1:1000.](http://images.novusbio.com/fullsize/GMF-beta-Antibody-Western-Blot-NBP2-43647-img0002.jpg)
![SDS-Page: Rat GMF-beta Protein [NBP2-35207]](http://images.novusbio.com/fullsize/Rat-GMF-beta-Protein-SDS-Page-NBP2-35207-img0001.jpg "SDS-Page: Rat GMF-beta Protein [NBP2-35207]")
![SDS-Page: Recombinant Human GMF-beta Protein [NBP2-34900]](http://images.novusbio.com/fullsize/Recombinant-Human-GMF-beta-Protein-SDS-Page-NBP2-34900-img0002.jpg "SDS-Page: Recombinant Human GMF-beta Protein [NBP2-34900]")
![Western Blot: GMF-beta Antibody (44D8) [NBP2-59490] - Lane 1: 293T cell lysates, Lane 2: GMFB transfected 293T cell lysates](http://images.novusbio.com/fullsize/GMF-beta-Antibody-44D8-Western-Blot-NBP2-59490-img0001.jpg "Western Blot: GMF-beta Antibody (44D8) [NBP2-59490] - Lane 1: 293T cell lysates, Lane 2: GMFB transfected 293T cell lysates")
![Immunocytochemistry/Immunofluorescence: GMF-beta Antibody (44D8) [NBP2-59490] - Analysis of GMFB in HeLa cells line, stained with DAPI (Blue) for nucleus staining and monoclonal anti-human GMFB antibody (1:100) with goat anti-mouse IgG-Alexa fluor 488 conjugate (Green).](http://images.novusbio.com/fullsize/GMF-beta-Antibody-44D8-Immunocytochemistry-Immunofluorescence-NBP2-59490-img0002.jpg)
![Western Blot: GMF-beta Antibody [NBP2-98937] - Anti-GMF-beta rabbit polyclonal antibody at 1:500 dilution. Lane A: HepG2 Whole Cell Lysate. Lane B: Jurkat Whole Cell Lysate. Lane C: Raji Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 17 kDa. Observed band size: 17 kDa (We are unsure as to the identity of these extra bands).](http://images.novusbio.com/fullsize/GMF-beta-Antibody-Western-Blot-NBP2-98937-img0003.jpg "Western Blot: GMF-beta Antibody [NBP2-98937] - Anti-GMF-beta rabbit polyclonal antibody at 1:500 dilution. Lane A: HepG2 Whole Cell Lysate. Lane B: Jurkat Whole Cell Lysate. Lane C: Raji Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 17 kDa. Observed band size: 17 kDa (We are unsure as to the identity of these extra bands).")
![Immunocytochemistry/Immunofluorescence: GMF-beta Antibody [NBP2-98937] - Immunofluorescence staining of GMF-beta in HeLa cells. Cells were fixed with 4% PFA, blocked with 10% serum, and incubated with NBP2-98937 antibody (1:1000) at 4C overnight. Then cells were stained with the Alexa Fluor(R)594-conjugated Goat Anti-rabbit IgG secondary antibody (red).Positive staining was localized to cytoplasm and nucleus.](http://images.novusbio.com/fullsize/nbp2-98937_rabbit-polyclonal-gmf-beta-antibody-235202514331591.png)
![Western Blot: GMF-beta Antibody (2G12-2A2) [H00002764-M01] - GMFB monoclonal antibody (M01), clone 2G12-2A2 Analysis of GMFB expression in Jurkat.](http://images.novusbio.com/fullsize/GMF-beta-Antibody-2G12-2A2-Western-Blot-H00002764-M01-img0005.jpg "Western Blot: GMF-beta Antibody (2G12-2A2) [H00002764-M01] - GMFB monoclonal antibody (M01), clone 2G12-2A2 Analysis of GMFB expression in Jurkat.")
![Immunocytochemistry/Immunofluorescence: GMF-beta Antibody (2G12-2A2) [H00002764-M01] - Analysis of monoclonal antibody to GMFB on HeLa cell. Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/GMF-beta-Antibody-2G12-2A2-Immunocytochemistry-Immunofluorescence-H00002764-M01-img0004.jpg)
![ELISA: Human GMF-beta ELISA Kit (Colorimetric) [NBP2-82177] - Samples were spiked with high concentrations of Human GMF-beta and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.](http://images.novusbio.com/fullsize/nbp2-82177_human-gmf-beta-elisa-kit-colorimetric-13220241625402.jpg "ELISA: Human GMF-beta ELISA Kit (Colorimetric) [NBP2-82177] - Samples were spiked with high concentrations of Human GMF-beta and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.")
![ELISA: Human GMF-beta ELISA Kit (Colorimetric) [NBP2-82177] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp2-82177_human-gmf-beta-elisa-kit-colorimetric-432024924083.jpg)
![ELISA: Rat GMF-beta ELISA Kit (Colorimetric) [NBP2-82179] - Samples were spiked with high concentrations of Rat GMF-beta and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.](http://images.novusbio.com/fullsize/nbp2-82179_rat-gmf-beta-elisa-kit-colorimetric-132202416235723.jpg "ELISA: Rat GMF-beta ELISA Kit (Colorimetric) [NBP2-82179] - Samples were spiked with high concentrations of Rat GMF-beta and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.")
![ELISA: Rat GMF-beta ELISA Kit (Colorimetric) [NBP2-82179] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp2-82179_rat-gmf-beta-elisa-kit-colorimetric-4320249115665.jpg)